Galectin Therapeutics Inc. – Transcripts

NASDAQ: GALT
Share price (6/26/26): $4.99
Market cap (6/26/26): $329 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Other Revised 03/10/26 Galectin Therapeutics Inc. - Special Call 03/10/26

CY 2025

Other Revised 06/16/25 Galectin Therapeutics Inc. - Special Call 06/16/25

CY 2021

Other Revised 12/03/21 Galectin Therapeutics Inc. - Shareholder/Analyst Call 12/03/21

CY 2020

Other Revised 12/03/20 Galectin Therapeutics, Inc. - Shareholder/Analyst Call 12/03/20

Other Revised 09/29/20 Galectin Therapeutics, Inc. - Special Call 09/29/20

CY 2019

Other Revised 12/04/19 Galectin Therapeutics, Inc. - Shareholder/Analyst Call 12/04/19